FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, and concerns a combination of pyrrolidone-5-carboxylic acid, with at least one of the compounds specified in citrulline, arginine and asparagine in the racemic form or in the form of D- or L-isomer, and/or their salts to be used for treating atopic dermatitis. The present group of inventions also concerns a composition to be used for treating or preventing atopic dermatitis and containing pyrrolidone-5-carboxylic acid with one of the compounds specified in citrulline, arginine and asparagine in the racemic form or in the form of D- or L-isomer, and/or their salts in a physiologically acceptable carrier.
EFFECT: group of inventions provides better water absorption as compared with any of the declared amino acids.
17 cl, 3 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| EXTERNAL THERAPEUTIC AGENT FOR PATIENTS SUFFERING ATOPIC DERMATITIS | 2012 |
|
RU2496476C1 |
| L-SERINE APPLICABLE AS THERAPEUTIC AGENT FOR PREVENTING AND/OR TREATING INFLAMMATORY SKIN RESPONSES | 2010 |
|
RU2554482C2 |
| COMPOSITIONS CONTAINING CROMOGLYCIC ACID FOR TREATMENT OF DERMATITIS | 2017 |
|
RU2754006C2 |
| SYSTEM OF TRANSDERMAL TRANSFER ENHANCERS AND COSMETIC COMPOSITIONS BASED THEREON | 2020 |
|
RU2736504C1 |
| STABILISED COMPOSITIONS FOR LOCAL APPLICATION, CONTAINING KETOPROFEN | 2004 |
|
RU2340335C2 |
| COMPOSITION FOR SKIN PROTECTION FROM EXPOSURE TO HARMFUL SUBSTANCES, LIGHT AND STRESS | 2021 |
|
RU2792212C1 |
| COMPOSITION FOR REDUCING INJURY CAUSED BY UV RADIATION | 2010 |
|
RU2537187C2 |
| ASCOMYCIN-CONTAINING COMPOSITIONS FOR TOPICAL APPLICATION | 1999 |
|
RU2234319C2 |
| COMPOSITION COMPRISING PROBIOTIC BACTERIA OR COMPONENTS THEREOF, AND METHOD FOR USE THEREOF IN TREATING IMMUNE SKIN DISEASES | 2017 |
|
RU2699540C2 |
| SEPARATION OF 3-AMINOALKYLNITRYLES | 2004 |
|
RU2309145C1 |
